Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angal vs Anti-Angin Lozenges for Sore Throat
NCT03095521Phase 3Completed
- Sponsor
- Sandoz
- Start
- Feb 2017
- Primary completion
- May 2017
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in pharyngitis and tonsillitis (2 arms), sponsored by Sandoz. Primary endpoint: Percentage of Participants Without Sore Throat According to TSS Score at 4 days. Started Feb 2017; status: completed.
02
Conditions
pharyngitistonsillitis
Beyond the preview
Go deeper on NCT03095521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03095521.